NellOne Therapeutics, Inc.
PrivateLast Round
Grant
Apr 26, 2021
Total Funding Raised
$1.75M
Company Overview
NellOne Therapeutics, Inc. operates in Healthcare & Life Sciences and is based in Knoxville, Tennessee. Its latest recorded funding round was a Grant round in April 2021.
NellOne Therapeutics, Inc. is a biotechnology company that develops regenerative protein-based therapies to restore damaged soft and hard tissue.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NellOne Therapeutics, Inc. Comparables
Compare NellOne Therapeutics, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theradaptive | 72% | |
| Medtronic | 63% | |
| KeraNetics | 63% |
For institutional investors. Book with your work email.
NellOne Therapeutics, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 26, 2021 | ||||
| Seed | Jun 4, 2008 |
For institutional investors. Book with your work email.
NellOne Therapeutics, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Battelle Ventures | Seed |
| Three Roots Capital | Angel |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 26, 2021
$250K grant awarded by the National Science Foundation.
- Jun 4, 2008
$2M raised, led by Battelle Ventures.
For institutional investors. Book with your work email.
NellOne Therapeutics, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NellOne Therapeutics, Inc.'s valuation, stock price, and market status.
Is NellOne Therapeutics, Inc. a public or private company?
NellOne Therapeutics, Inc. is a private company.
What is the current stock price of NellOne Therapeutics, Inc.?
NellOne Therapeutics, Inc. is a private company, so its shares have no public market price. Caplight tracks NellOne Therapeutics, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NellOne Therapeutics, Inc. worth (valuation)?
Valuation information for NellOne Therapeutics, Inc. is not publicly available.
Can I buy NellOne Therapeutics, Inc. stock?
NellOne Therapeutics, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NellOne Therapeutics, Inc.'s last funding round?
NellOne Therapeutics, Inc.'s most recent funding round was Grant on April 26, 2021.
Who are the main investors in NellOne Therapeutics, Inc.?
Key investors in NellOne Therapeutics, Inc. include Battelle Ventures.
Will NellOne Therapeutics, Inc. IPO soon?
No public IPO plans have been announced for NellOne Therapeutics, Inc..
How can I track NellOne Therapeutics, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in NellOne Therapeutics, Inc.'s shares on secondary markets.